Litigator of the Week Runners-Up and Shout Outs
Latham team recognized for knocking out shareholder claims against client Sinovac Biotech.
Ryan Schachne is an associate in the New York office of Latham & Watkins.
Mr. Schachne advises clients on securities and class action litigation, SEC and other regulatory investigations, and complex commercial litigation. Mr. Schachne’s clients consist of financial institutions and large public companies.
While at the New York University School of Law, Mr. Schachne was a staff development editor of the Review of Law and Social Change and interned with the Federal Defenders of New York.
Mr. Schachne has represented several global companies and their directors and officers in federal securities class actions and derivative suits. These companies span numerous industries, including technology, telecommunications, pharmaceutical, and financial services.
Mr. Schachne’s relevant experience includes:
Latham team recognized for knocking out shareholder claims against client Sinovac Biotech.
Latham recognized for securing the complete dismissal of a federal securities stock drop case for Frequency Therapeutics Inc. and certain of its senior executives.
Three Latham wins recognized in the legal publication’s prestigious weekly contest.